Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading Pure Play in Regenerative Medicine

Go back to Ascendiant Capital Starts Aastrom Biosciences (ASTM) at Strong Buy; Leading Pure Play in Regenerative Medicine